Clinical trials
Phase 2 Neuroectodermal Tumors trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
5 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 1 |
| 2010 | 2 |
| 2016 | 1 |
| 2019 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 4 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| DNAtrix, Inc. | 1 |
| Jubilant DraxImage Inc. | 1 |
| National Cancer Institute (NCI) | 1 |
| University of Florida | 1 |
| Yale University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neuroectodermal Tumors | 5 |
| Neoplasms | 3 |
| Neoplasms, Nerve Tissue | 2 |
| Neuroblastoma | 2 |
| Adenocarcinoma | 1 |
| Adrenocortical Carcinoma | 1 |
| Brain Neoplasms | 1 |
| Carcinoma | 1 |
| Carcinoma, Neuroendocrine | 1 |
| Colonic Diseases | 1 |
Trials
Showing 1 to 5 of 5. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.